Edwards Lifesciences | EW - Fremdkapital

Aktienkurs
82.39
Täglich Wechseln
1.01 1.24%
Monatlich
1.17%
Jährlich
5.57%
Q2 Prognose
79.74




Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Artivion USD 215.35M 2.46M 2026-03
AtriCure USD 61M 865K 2026-03
Baxter International USD 8.62B 852M 2026-03
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Boston Scientific USD 11.01B 19M 2025-12
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.3B 54.4M 2026-03
Edwards Lifesciences USD 600M 1.7M 2026-03
Globus Medical USD 436K 9K 2025-12
ICU Medical USD 1.26B 4.09M 2026-03
Inogen USD 0 0 2022-06
Insulet USD 929.5M 1.3M 2026-03
Integra LifeSciences USD 1.83B 29.45M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.53B 1.91B 2026-03
Masimo USD 445.7M 72.3M 2026-03
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 735.16M 1.12M 2026-03
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 601.77M 291.73M 2026-03
Teleflex USD 2.51B 27.18M 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03